Pritesh Shah
2018
In 2018, Pritesh Shah earned a total compensation of $3.1M as Chief Commercial Officer at NovoCure.
Compensation breakdown
| Non-Equity Incentive Plan | $265,625 |
|---|---|
| Option Awards | $1,616,575 |
| Salary | $400,000 |
| Stock Awards | $768,196 |
| Other | $20,100 |
| Total | $3,070,496 |
Shah received $1.6M in option awards, accounting for 53% of the total pay in 2018.
Shah also received $265.6K in non-equity incentive plan, $400K in salary, $768.2K in stock awards and $20.1K in other compensation.
Rankings
In 2018, Pritesh Shah's compensation ranked 3,781st out of 14,244 executives tracked by ExecPay. In other words, Shah earned more than 73.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,781 out of 14,244 | 74th |
Division Manufacturing | 1,400 out of 5,759 | 76th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 172 out of 849 | 80th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 96 out of 547 | 82nd |
Industry Surgical and Medical Instruments and Apparatus | 62 out of 348 | 82nd |
Source: SEC filing on April 10, 2019.
Shah's colleagues
We found five more compensation records of executives who worked with Pritesh Shah at NovoCure in 2018.